Peter Godfrey-Faussett
Overview
Explore the profile of Peter Godfrey-Faussett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
2460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DOttavi M, Godfrey-Faussett P, Merle C, Sofonea M, Laureillard D, Vickerman P, et al.
Lancet Glob Health
. 2025 Jan;
13(3):e593-e598.
PMID: 39862874
People who use drugs show a higher incidence and prevalence of tuberculosis than people who do not use drugs in areas where Mycobacterium tuberculosis is endemic. However, this population is...
2.
Yang C, Shih Y, Ayles H, Godfrey-Faussett P, Claassens M, Lin H
J Glob Health
. 2024 Nov;
14:04226.
PMID: 39575610
Background: Active case finding could effectively detect tuberculosis (TB) patients, but it can be costly. Therefore, a feasible, cost-saving, and efficient algorithm for community-based TB screening is needed. Methods: The...
3.
Bailey S, Floyd S, Cheeba-Lengwe M, Maluzi K, Chiwele-Kangololo K, Kaluba-Milimo D, et al.
J Epidemiol Glob Health
. 2024 May;
14(3):914-922.
PMID: 38713341
Objectives: To determine if HIV modifies the association between hyperglycaemia and active tuberculosis in Lusaka, Zambia. Methods: A case-control study among newly-diagnosed adult tuberculosis cases and population controls in three...
4.
Monod M, Brizzi A, Galiwango R, Ssekubugu R, Chen Y, Xi X, et al.
Nat Microbiol
. 2023 Dec;
9(1):35-54.
PMID: 38052974
HIV incidence in eastern and southern Africa has historically been concentrated among girls and women aged 15-24 years. As new cases decline with HIV interventions, population-level infection dynamics may shift...
5.
Monod M, Brizzi A, Galiwango R, Ssekubugu R, Chen Y, Xi X, et al.
medRxiv
. 2023 Mar;
PMID: 36993261
HIV incidence in eastern and southern Africa has historically been concentrated among girls and women aged 15-24 years. As new cases decline with HIV interventions, population-level infection dynamics may shift...
6.
Torres-Rueda S, Terris-Prestholt F, Gafos M, Indravudh P, Giddings R, Bozzani F, et al.
Pharmacoeconomics
. 2023 Mar;
41(7):787-802.
PMID: 36905570
Background And Objective: Although HIV prevention science has advanced over the last four decades, evidence suggests that prevention technologies do not always reach their full potential. Critical health economics evidence...
7.
Murphy E, Doherty M, El Sadr W, Zaidi I, Kamarazulman A, Crowley S, et al.
Lancet HIV
. 2022 Nov;
9(12):e884-e886.
PMID: 36354047
During 2020, the COVID-19 pandemic disrupted the delivery of HIV prevention and treatment services globally. To mitigate the negative consequences of the pandemic, service providers and communities adapted and accelerated...
8.
Godfrey-Faussett P, Frescura L, Abdool Karim Q, Clayton M, Ghys P
PLoS Med
. 2022 Sep;
19(9):e1004102.
PMID: 36156593
UNAIDS and a broad range of partners have collaborated to establish a new set of HIV prevention targets to be achieved by 2025 as an intermediate step towards the sustainable...
9.
Frescura L, Godfrey-Faussett P, Feizzadeh A A, El-Sadr W, Syarif O, Ghys P
PLoS One
. 2022 Aug;
17(8):e0272405.
PMID: 35925943
In December 2020, UNAIDS released a new set of ambitious targets calling for 95% of all people living with HIV to know their HIV status, 95% of all people with...
10.
Phillips A, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily M, et al.
Lancet HIV
. 2022 Apr;
9(5):e353-e362.
PMID: 35489378
Background: Approaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-counter provision at pharmacies, could facilitate risk-informed PrEP use and lead to lower HIV incidence, but their cost-effectiveness...